Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza

Trial Profile

A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza

Recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Sep 2018

At a glance

  • Drugs Nitazoxanide (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Sponsors Romark Laboratories
  • Most Recent Events

    • 28 Aug 2018 Planned End Date changed from 1 Oct 2018 to 1 Apr 2019.
    • 28 Aug 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Apr 2019.
    • 09 Feb 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top